Clorox (NYSE:CLX) Updates FY 2025 Earnings Guidance

Clorox (NYSE:CLX) updated its FY 2025 earnings guidance on Monday. The company provided earnings per share guidance of 6.950-7.350 for the period, compared to the consensus earnings per share estimate of 6.870. The company issued revenue guidance of $7.0 billion-$7.0 billion, compared to the consensus revenue estimate of $7.1 billion.

Clorox Price Performance

Shares of NYSE:CLX traded down $1.41 during trading on Wednesday, hitting $146.80. 749,984 shares of the stock were exchanged, compared to its average volume of 1,274,227. Clorox has a 12-month low of $127.60 and a 12-month high of $171.37. The company has a market cap of $18.17 billion, a PE ratio of 51.16, a P/E/G ratio of 2.92 and a beta of 0.42. The company has a fifty day moving average price of $162.25 and a two-hundred day moving average price of $158.76. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last posted its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.08% and a net margin of 4.78%. During the same period last year, the business earned $2.16 EPS. On average, analysts forecast that Clorox will post 6.86 EPS for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.32%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on CLX shares. Wells Fargo & Company lifted their price objective on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday. DA Davidson cut their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and increased their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Barclays boosted their target price on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday. Finally, Evercore ISI raised their price target on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, Clorox presently has a consensus rating of “Hold” and an average target price of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.